Jeisys Medical Inc
KOSDAQ:287410
Balance Sheet
Balance Sheet Decomposition
Jeisys Medical Inc
Current Assets | 128.6B |
Cash & Short-Term Investments | 80.8B |
Receivables | 16.1B |
Other Current Assets | 31.7B |
Non-Current Assets | 76.2B |
Long-Term Investments | 30.4B |
PP&E | 39.6B |
Intangibles | 1.8B |
Other Non-Current Assets | 4.5B |
Balance Sheet
Jeisys Medical Inc
Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Cash & Cash Equivalents |
1 394
|
1 168
|
1 116
|
25
|
34 291
|
39 583
|
48 830
|
|
Cash |
0
|
0
|
0
|
0
|
9
|
0
|
0
|
|
Cash Equivalents |
1 394
|
1 168
|
1 116
|
25
|
34 282
|
39 583
|
48 830
|
|
Short-Term Investments |
0
|
7 000
|
7 105
|
8 210
|
0
|
0
|
0
|
|
Total Receivables |
0
|
84
|
98
|
81
|
7 402
|
10 916
|
15 575
|
|
Accounts Receivables |
0
|
83
|
82
|
58
|
7 057
|
10 344
|
14 050
|
|
Other Receivables |
0
|
0
|
16
|
23
|
344
|
572
|
1 525
|
|
Inventory |
0
|
0
|
0
|
0
|
10 578
|
20 380
|
22 617
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
1 902
|
3 605
|
3 488
|
|
Total Current Assets |
1 394
|
8 252
|
8 320
|
8 316
|
54 173
|
74 483
|
90 510
|
|
PP&E Net |
0
|
0
|
0
|
0
|
10 750
|
22 140
|
34 660
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
10 750
|
22 140
|
34 660
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
7 055
|
5 916
|
7 823
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
969
|
1 708
|
1 905
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
258
|
7 748
|
9 528
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
7 908
|
12 038
|
5 709
|
|
Total Assets |
1 394
N/A
|
8 252
+492%
|
8 320
+1%
|
8 316
0%
|
74 059
+791%
|
118 118
+59%
|
142 313
+20%
|
|
Liabilities | ||||||||
Accounts Payable |
0
|
0
|
0
|
0
|
2 364
|
2 310
|
3 512
|
|
Accrued Liabilities |
2
|
0
|
0
|
0
|
2 586
|
3 844
|
2 966
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
3 257
|
3 287
|
1 304
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
7 365
|
1 661
|
2 032
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
8 455
|
15 482
|
13 705
|
|
Total Current Liabilities |
2
|
0
|
0
|
0
|
24 027
|
26 583
|
23 519
|
|
Long-Term Debt |
540
|
563
|
587
|
613
|
1 729
|
11 315
|
22 271
|
|
Deferred Income Tax |
26
|
25
|
29
|
20
|
0
|
0
|
0
|
|
Minority Interest |
0
|
0
|
0
|
0
|
568
|
537
|
1 243
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
649
|
264
|
273
|
|
Total Liabilities |
568
N/A
|
588
+4%
|
617
+5%
|
633
+3%
|
26 973
+4 160%
|
38 700
+43%
|
47 306
+22%
|
|
Equity | ||||||||
Common Stock |
74
|
424
|
424
|
424
|
7 130
|
7 130
|
7 647
|
|
Retained Earnings |
6
|
10
|
30
|
9
|
6 865
|
33 995
|
58 796
|
|
Additional Paid In Capital |
758
|
7 250
|
7 250
|
7 250
|
26 849
|
26 421
|
26 271
|
|
Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
34
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
264
|
264
|
10 265
|
|
Other Equity |
0
|
0
|
0
|
1
|
6 505
|
12 135
|
12 524
|
|
Total Equity |
826
N/A
|
7 663
+828%
|
7 703
+1%
|
7 682
0%
|
47 086
+513%
|
79 418
+69%
|
95 006
+20%
|
|
Total Liabilities & Equity |
1 394
N/A
|
8 252
+492%
|
8 320
+1%
|
8 316
0%
|
74 059
+791%
|
118 118
+59%
|
142 313
+20%
|
|
Shares Outstanding | ||||||||
Common Shares Outstanding |
1
|
4
|
4
|
4
|
71
|
71
|
75
|